Immunoprecise Antibodies LtdNASDAQ:IPANASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.3860
- TODAY'S CHANGE (%)0.0040 (1.0471%)
- Bid / Lots0.3801/ 4
- Ask / Lots0.4100/ 5
- Open / Previous Close0.4100 / 0.3820
- Day Range
- 52 Week Range
- Volume193,667
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IPA |
|---|---|---|
| 09:32 ET | 56086 | 0.4 |
| 09:37 ET | 2000 | 0.3904 |
| 09:39 ET | 500 | 0.4 |
| 09:42 ET | 1133 | 0.3952 |
| 09:44 ET | 2500 | 0.4 |
| 09:46 ET | 900 | 0.398 |
| 09:55 ET | 12456 | 0.415 |
| 10:00 ET | 7998 | 0.40555 |
| 10:08 ET | 689 | 0.4 |
| 10:13 ET | 11750 | 0.3962 |
| 10:15 ET | 2623 | 0.396 |
| 10:38 ET | 1000 | 0.411457 |
| 10:40 ET | 1087 | 0.4027 |
| 10:42 ET | 1000 | 0.4027 |
| 11:00 ET | 537 | 0.3917 |
| 11:02 ET | 200 | 0.4 |
| 11:07 ET | 110 | 0.4 |
| 11:09 ET | 500 | 0.39916 |
| 11:12 ET | 863 | 0.395 |
| 11:16 ET | 137 | 0.395 |
| 11:21 ET | 2874 | 0.4 |
| 11:25 ET | 15400 | 0.40505 |
| 11:27 ET | 5000 | 0.40505 |
| 11:30 ET | 200 | 0.405 |
| 11:36 ET | 600 | 0.4002 |
| 11:39 ET | 100 | 0.405 |
| 11:41 ET | 200 | 0.4 |
| 11:45 ET | 489 | 0.4001 |
| 11:48 ET | 5553 | 0.4 |
| 11:57 ET | 298 | 0.4001 |
| 11:59 ET | 100 | 0.4 |
| 12:01 ET | 4337 | 0.4001 |
| 12:03 ET | 1500 | 0.4001 |
| 12:12 ET | 1000 | 0.405 |
| 12:19 ET | 4315 | 0.41 |
| 12:21 ET | 200 | 0.4001 |
| 12:24 ET | 137 | 0.41 |
| 12:26 ET | 200 | 0.4 |
| 12:33 ET | 1100 | 0.405 |
| 12:35 ET | 100 | 0.4001 |
| 12:48 ET | 779 | 0.4001 |
| 01:00 ET | 100 | 0.4 |
| 01:04 ET | 700 | 0.4 |
| 01:06 ET | 7519 | 0.4 |
| 01:15 ET | 4400 | 0.4 |
| 01:22 ET | 975 | 0.394281 |
| 01:45 ET | 100 | 0.409 |
| 01:58 ET | 881 | 0.41 |
| 02:00 ET | 200 | 0.3918 |
| 02:12 ET | 354 | 0.392 |
| 02:14 ET | 127 | 0.3917 |
| 02:16 ET | 127 | 0.3904 |
| 02:23 ET | 111 | 0.3904 |
| 02:25 ET | 100 | 0.39 |
| 02:34 ET | 333 | 0.41 |
| 02:43 ET | 1723 | 0.3877 |
| 02:54 ET | 802 | 0.39 |
| 02:57 ET | 300 | 0.396435 |
| 02:59 ET | 1649 | 0.39 |
| 03:06 ET | 691 | 0.4099 |
| 03:08 ET | 300 | 0.39 |
| 03:14 ET | 100 | 0.395 |
| 03:17 ET | 106 | 0.395 |
| 03:24 ET | 306 | 0.38 |
| 03:28 ET | 231 | 0.395 |
| 03:30 ET | 500 | 0.41 |
| 03:32 ET | 164 | 0.38 |
| 03:37 ET | 172 | 0.38 |
| 03:39 ET | 1646 | 0.38 |
| 03:42 ET | 208 | 0.386 |
Nov 13, 2024
$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies, from 9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 4, 2024
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation, from 8:01AM ET on Monday Nov 04, 2024 by Dow Jones
8:01AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 28, 2024
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology, from 7:30AM ET on Monday Oct 28, 2024 by Dow Jones
7:30AM ET on Monday Oct 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Immunoprecise Antibodies Ltd | 10.8M | -0.5x | --- |
Todos Medical Ltd | 2.1K | 0.0x | --- |
LakeShore Biopharma Co Ltd | 50.0M | -0.6x | --- |
TRACON Pharmaceuticals Inc | 107.5K | 0.0x | --- |
Medicure Inc | 6.7M | -3.7x | --- |
Syros Pharmaceuticals Inc | 7.9M | -0.1x | --- |
Company Information
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Contact Information
- Headquarters
- 3204-4464 Markham St.VICTORIA, BC, Canada V8Z 7X8
- Phone
- 604-806-0626
- Fax
- 250-483-0309
Executives
- Chairman of the Board
- Mitch Levine
- President, Chief Executive Officer, Director
- Jennifer Bath
- Chief Financial Officer
- Kristin Taylor
- Chief Scientific Officer
- Ilse Roodink
- Vice President - Commercial Services
- Kari Graber
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.8M |
|---|---|
Revenue (TTM) | $17.2M |
Shares Outstanding | 28.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.22 |
EPS | $-0.75 |
Book Value | $0.90 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -123.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
